TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 51.80
+1.20 (2.37%)
Mar 4, 2026, 9:50 AM CST
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 13.82 billion as of March 3, 2026. Its market cap has decreased by -41.00% in one year.
Market Cap
13.82B
Enterprise Value
12.56B
Revenue
607.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.80
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 13.82B, an increase of 435.72%. That is a compound annual growth rate of 11.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 14.29B | -14.54% |
| Dec 31, 2025 | 16.72B | -28.81% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sunmax Biotechnology | 21.16B |
| EirGenix | 18.34B |
| AP Biosciences | 15.15B |
| Ever Supreme Bio Technology | 13.49B |
| Tanvex BioPharma | 12.96B |
| Medigen Vaccine Biologics | 11.67B |
| TCM Biotech International | 11.57B |
| Gongwin Biopharm Holdings | 9.86B |